Private credit's bottleneck moved from origination to the shelf
Amundi, CIFC, SVP and HarbourVest paid for allocator access in four currencies this week, as insurance balance sheets and UK pension defaults became the buyers worth reaching.
Amundi is paying €620m for 9.9 per cent of ICG, and the equity is the smaller half of what it bought: attached to the stake is a ten-year exclusive on ICG's evergreen products, making Amundi the channel through which those vehicles travel for a decade. Priced on their own, the shares imply an ICG value near €6.3bn—a number that describes the firm's earnings power and says nothing about the part Amundi was actually bidding for.
A decade is long enough to cover a fundraising cycle and the trough that follows it, and evergreen credit funds depend on subscriptions that arrive continuously rather than in a single close, so continuous subscriptions need an allocator-facing channel that does not have to be rebuilt with every vintage. Distribution used to be something a manager hired at the end of the process; here it is the asset bought at the beginning of one, and this week it acquired a price.
A minority stake with a distribution exclusivity attached reads as a template any manager with evergreen product could sell, and evergreen credit is where the supply of product is growing fastest. Managers who own their distribution have something to offer other than equity in their underwriting; managers who do not have a line item they cannot avoid.
Evergreen vehicles charge fees on assets that stay, so ten years of exclusive distribution is ten years of fee-bearing flows rather than a single commitment. The buyer of the channel captures the compounding while the manager keeps the underwriting, and the €620m for that stream is a judgment about how much of ICG's evergreen book Amundi can actually move—a figure the deal does not disclose.
A ten-year exclusivity is worth what the underlying product is worth in year eight, and evergreen credit is a category whose appeal is tied to a spread that moves. If the yield premium over traded credit narrows, Amundi will own a decade of distribution rights on vehicles that sell harder than they did the day the cheque cleared—a real risk, and a familiar one in distribution deals, where the channel is bought at today's price and repriced by the market later.
The money is not the constraint
Nothing in this week's credit coverage suggests private credit is short of capital: Carlyle closed an infrastructure credit fund at $2.3bn, three times its predecessor and above target, KKR's credit book is up 50 per cent, and Hayfin's fifth European fund closed at €15bn in a year when European private credit volume is running 30 per cent behind 2025, bought as diversification from America rather than as a wager on European deal flow. When a raise of that size needs a hedge attached before it can be sold, capital is not what is missing.
The menu is what is missing. Origination has stopped being the hard part of the business, and a market that closes a $2.3bn infrastructure credit fund at three times the previous vintage and a €15bn European vehicle into a shrinking region has more money chasing loans than loans worth chasing. The scarce resource is a place to put the product where an allocator will find it, and that scarcity is being paid for in equity, titles and hiring.
Hold the price tags against each other: Amundi's price is a fraction of the $2.3bn Carlyle raised for one infrastructure credit fund and a fraction of Hayfin's €15bn. The sums spent on distribution are small next to the sums raised for product, which is what a market looks like when capital is abundant and access is not.
Four receipts for the same purchase
Amundi's stake, CIFC's shelf, SVP's president and HarbourVest's secondaries hire landed within two days of one another, four firms answering the same question: where does the next dollar of private credit product get sold?
CIFC is paying in shelf space, putting a $47bn covenant-heavy, floating-rate book on a wealth menu where advisers compare yield first and documentation second—two facts that pull against each other. A covenant package protects a coupon in a bad year and is also the hardest thing to explain in a sales meeting, so leading with covenants to a wealth audience is a wager that the channel will eventually price protection rather than headline yield. That wager is probably right over five years and expensive over one, because a platform's menu holds only so many slots.
SVP paid in a title, handing its president's chair to Goldman's distribution chief with a remit covering client relations, firmwide infrastructure and a power-and-infrastructure sourcing brief—the whole firm, in effect, apart from the investing. A distribution hire at that altitude says the binding constraint is allocator access rather than underwriting, and the sourcing brief says the same relationship is expected to work in both directions, bringing capital in and deals out.
HarbourVest paid in a seat, and chose the most instructive one of the three: it staffed evergreen credit from the secondaries side, placing the desk that prices exits inside the product that promises them. An evergreen fund's liquidity is only ever as good as its ability to price a loan it did not originate and may need to sell before maturity, and hiring that judgment from secondaries rather than from the origination team says which skill the redemption promise actually rests on.
Four firms, four currencies, one purchase—access to an allocator list somebody else built. Amundi bought a decade of it in Europe, CIFC is renting it by the slot on US wealth platforms, SVP hired the person who knows how to construct one, and HarbourVest is making its own liquidity promise credible enough to survive a bad month; none of the four is spending on origination.
Insurance first, UK pensions later
Who sits at the end of the channel matters, because the menu is being assembled for two buyer classes that did not used to lead the queue. The first is the insurance balance sheet, private credit's biggest allocator: Allianz's $146.3bn tops the GI 75, and the asset menus below that number tell managers which buyer now sets the terms. Insurance capital tends to be duration-aware and spread-sensitive, meaning it wants the covenant-protected, floating-rate exposure CIFC is pitching to wealth without needing a wealth platform to find it.
The second buyer barely exists yet: Standard Life projects private markets at 15 to 30 per cent of UK defined contribution default funds by 2035, with credit taking 20 to 40 per cent of the private sleeve—multiply the ranges and the arithmetic lands between 3 and 12 per cent of a default fund in private credit. Even the bottom of that band would turn UK workplace pensions into an allocator class with governance committees and an investment line item, a far larger buyer than the discretionary ticket anchoring private credit's wealth push today.
The week also cuts the other way: if the biggest allocators—insurance balance sheets—buy directly and do not need a wealth menu, then CIFC and its peers are paying for a channel that matters less than the queue for it suggests. The evidence against that reading is SVP, where a firm with credit expertise put distribution in charge of everything but the investing; that is not what a manager does when it believes the product sells itself.
The Amundi price matters more than its size for that reason. If the marginal buyer is shifting from institutions that judge managers on credit skill to institutions that judge fit with a menu they already use, underwriting becomes table stakes and shelf presence becomes the differentiator. That price will read as a cheap lease within two years, because the supply of evergreen credit product is growing faster than the number of channels that can credibly sell it. The next test is the second exclusivity: sell another minority stake with a decade of distribution attached and the template is set; come back with a shorter term at a similar price and the buyers will have learned something about how quickly a shelf goes stale.